Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole as adjunctive treatment to paroxetine or sertraline for PTSD
2012-004982-41Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brexpiprazole in post-traumatic stress disorder (PTSD), sponsored by Lundbeck. Started Oct 2013; status: terminated.
02
Drugs
brexpiprazole
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2012-004982-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004982-41.